July 20 (Reuters) - NuVasive Inc NUVA.O :
* NUVASIVE ANNOUNCES CERTAIN PRELIMINARY UNAUDITED SECOND
QUARTER
2020 RESULTS
* SEES Q2 2020 SALES $202 MILLION TO $205 MILLION
* NUVASIVE -IN ADDITION TO ADVERSE IMPACTS OF COVID-19 ON Q2
NET
SALES, WILL RECORD INCREMENTAL CHARGES PRIMARILY RESULTING FROM
PANDEMIC IMPACTS
* SAYS WILL RECOGNIZE Q2 OPERATING LOSS IN RANGE OF $35
MILLION TO
$40 MILLION ON GAAP BASIS AND $17 MILLION TO $23 MILLION ON
NON-GAAP BASIS
Source text for Eikon: ID:nPn4VQXHka
Further company coverage: NUVA.O
((Reuters.Briefs@thomsonreuters.com;))